Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.030
-0.040 (-1.93%)
Nov 4, 2025, 11:10 AM EST - Market open
Nkarta Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
157
Market Cap
144.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
NKTX News
- 4 days ago - Nkarta to Participate in November Investor Conferences - GlobeNewsWire
- 13 days ago - Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting - GlobeNewsWire
- 2 months ago - Nkarta to Participate in a September Investor Conference - GlobeNewsWire
- 2 months ago - Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 3 months ago - Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series - GlobeNewsWire
- 3 months ago - Nkarta: Holding Its Support Steady Ahead Of First Data Readouts In 2025 - Seeking Alpha
- 5 months ago - Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus - GlobeNewsWire
- 6 months ago - Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space - Benzinga